🇺🇸 FDA
Pipeline program

Bivamelagon

RM-MC72-002

Phase 2 small_molecule active

Quick answer

Bivamelagon for Hypothalamic Obesity is a Phase 2 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
RHYTHM PHARMACEUTICALS, INC.
Indication
Hypothalamic Obesity
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials